Scrip
River Plate/Alcon's dry eye treatment needs more study, US panel says
29 June 2009
Sue Sutter
The efficacy of River Plate Biotechnology/
Alcon's dry eye treatment Rejena (sodium hyaluronate ophthalmic solution, 0.18%) requires further study before approval, the US
FDA's dermatologic and ophthalmic drugs advisory panel has recommended.
In a six to one vote, the panel said adequate efficacy...
Please Login to read the full article.
29 June 2009
Sue Sutter
In a six to one vote, the panel said adequate efficacy...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Amarin focused on CV disease to pump new life into company
- Xention looks to ion technology to jump start safer treatments
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
